In development: Guidance, quality standards and advice
Showing 11 to 11 of 11
| Title | Type | Expected publication date |
|---|---|---|
| Tiragolumab with atezolizumab for untreated PD-L1-positive advanced non-small-cell lung cancer [ID5122] | Technology appraisal guidance | TBC |